M. Suttorp

Association between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan before Hematologic Stem Cell Transplantation

Imke H. Bartelink, Svetlana V. Belitser, M. Suttorp et al. · Biology of Blood and Marrow Transplantation · 2009 · 122 citations · Full text

Medicine, Hematology, Pediatrics +17

Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients

M. Suttorp, Tiny Hoekstra, Joris I. Rotmans et al. · BMC Nephrology · 2013 · 34 citations · Full text

Medicine, Hematology, Nephrology +14

Trends in haemoglobin, erythropoietin-stimulating agents and iron use in Swedish chronic kidney disease patients between 2008 and 2013

Marie Evans, M. Suttorp, Rino Bellocco et al. · Nephrology Dialysis Transplantation · 2015 · 26 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Treatment with high dose of erythropoiesis-stimulating agents and mortality: analysis with a sequential Cox approach and a marginal structural model

M. Suttorp, Tiny Hoekstra, Moshe Mittelman et al. · Pharmacoepidemiology and Drug Safety · 2015 · 24 citations · Full text

Medicine, Biostatistics, Pharmacology +16

Rapid engraftment of peripheral blood progenitor cell grafts purged with B cell-specific monoclonal antibodies and immunomagnetic beads.

Peter Dreger, Nils von Neuhoff, M. Suttorp et al. · PubMed · 1995 · 24 citations

Life Sciences, Hematology, Immunology +17